RGAAX
Price
$75.01
Change
+$0.40 (+0.54%)
Updated
Sep 11 closing price
Net Assets
353.07B
WPASX
Price
$47.57
Change
+$0.76 (+1.62%)
Updated
Sep 11 closing price
Net Assets
421.64M
Interact to see
Advertisement

RGAAX vs WPASX

RGAAX vs WPASX Comparison Chart in %
View a ticker or compare two or three
VS
RGAAX vs. WPASX commentary
Sep 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RGAAX is a Buy and WPASX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGAAX has more cash in the bank: 353B vs. WPASX (422M). RGAAX (0.00) and WPASX (0.00) have matching dividends . RGAAX was incepted earlier than WPASX: RGAAX (24 years) vs WPASX (13 years). RGAAX (1.37) is less costly to investors than WPASX (1.00). RGAAX is a more actively managed with annual turnover of: 32.00 vs. WPASX (18.00). RGAAX has a lower initial minimum investment than WPASX: RGAAX (250) vs WPASX (2500). RGAAX annual gain was more profitable for investors over the last year : -2.14 vs. WPASX (-15.44). RGAAX return over 5 years is better than : 4.72 vs. WPASX (-23.32).
RGAAXWPASXRGAAX / WPASX
Total Expense Ratio1.371.00137%
Annual Report Gross Expense Ratio1.371.00137%
Fund Existence24 years13 years-
Gain YTD8.490-6.268-135%
Front LoadN/A4%-
Min. Initial Investment250250010%
Min. Initial Investment IRAN/AN/A-
Net Assets353B422M83,649%
Annual Yield % from dividends0.000.00-
Returns for 1 year-2.14-15.4414%
Returns for 3 years35.28-3.84-918%
Returns for 5 years4.72-23.32-20%
Returns for 10 years84.8070.15121%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NAMS22.800.94
+4.30%
NewAmsterdam Pharma Company NV
BYRN3.620.09
+2.55%
Byrna Technologies
CX10.690.03
+0.28%
Cemex SAB de CV
RGNX8.53-0.03
-0.35%
REGENXBIO
CRIS1.13-0.03
-2.59%
Curis Inc.